Related references
Note: Only part of the references are listed.The Relationship between Anti-merozoite Antibodies and Incidence of Plasmodium falciparum Malaria: A Systematic Review and Meta-analysis
Freya J. I. Fowkes et al.
PLOS MEDICINE (2010)
Parasite threshold associated with clinical malaria in areas of different transmission intensities in north eastern Tanzania
Bruno P. Mmbando et al.
BMC MEDICAL RESEARCH METHODOLOGY (2009)
The Quantity and Quality of African Children's IgG Responses to Merozoite Surface Antigens Reflect Protection against Plasmodium falciparum Malaria
David Courtin et al.
PLOS ONE (2009)
Breadth and magnitude of antibody responses to multiple Plasmodium falciparum merozoite antigens are associated with protection from clinical malaria
Faith H. A. Osier et al.
INFECTION AND IMMUNITY (2008)
Cohort study of the association of antibody levels to AMA1, MSP119, MSP3 and GLURP with protection from clinical malaria in Ghanaian children
Daniel Dodoo et al.
MALARIA JOURNAL (2008)
Safety and Immunogenicity of a Recombinant Plasmodium falciparum AMA1 Malaria Vaccine Adjuvanted with Alhydrogel™, Montanide ISA 720 or AS02
Meta Roestenberg et al.
PLOS ONE (2008)
Humoral responses to Plasmodium falciparum blood-stage antigens and association with incidence of clinical malaria in children living in an area of seasonal malaria transmission in Burkina Faso, West Africa
Issa Nebie et al.
INFECTION AND IMMUNITY (2008)
Multiplex assay for simultaneous measurement of antibodies to multiple Plasmodium falciparum antigens
Genevieve G. Fouda et al.
CLINICAL AND VACCINE IMMUNOLOGY (2006)
Clinical case definitions and malaria vaccine efficacy
WO Rogers et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Immunological processes in malaria pathogenesis
L Schofield et al.
NATURE REVIEWS IMMUNOLOGY (2005)
Measurement of antibody levels against region II of the erythrocyte-binding antigen 175 of Plasmodium falciparum in an area of malaria holoendemicity in Western Kenya
EA Ohas et al.
INFECTION AND IMMUNITY (2004)
Human antibodies to recombinant protein constructs of Plasmodium falciparum Apical Membrane Antigen 1 (AMA1) and their associations with protection from malaria
SD Polley et al.
VACCINE (2004)
Clinical features and pathogenesis of severe malaria
CL Mackintosh et al.
TRENDS IN PARASITOLOGY (2004)
Seasonal profiles of malaria infection, anaemia, and bednet use among age groups and communities in northern Ghana
KA Koram et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2003)
Antibodies to the Plasmodium falciparum antigens circumsporozoite protein, thrombospondin-related adhesive protein, and liver-stage antigen 1 vary by ages of subjects and by season in a highland area of Kenya
CC John et al.
INFECTION AND IMMUNITY (2003)
Malaria-induced acquisition of antibodies to Plasmodium falciparum variant surface antigens
MF Ofori et al.
INFECTION AND IMMUNITY (2002)
Pre-erythrocytic immunity to Plasmodium falciparum:: the case for an LSA-1 vaccine
JD Kurtis et al.
TRENDS IN PARASITOLOGY (2001)
Analysis of human antibodies to erythrocyte binding antigen 175 of Plasmodium falciparum
DMN Okenu et al.
INFECTION AND IMMUNITY (2000)
Cytophilic immunoglobulin responses to Plasmodium falciparum glutamate-rich protein are correlated with protection against clinical malaria in Dielmo, Senegal
C Oeuvray et al.
INFECTION AND IMMUNITY (2000)
Immune response to Plasmodium falciparum liver stage antigen-1: geographical variations within Central Africa and their relationship with protection from clinical malaria
F Migot-Nabias et al.
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2000)
Share Paper
